Brian Penman

Fidelity Investments Canada ULC (FIC) is a Canadian investment advisor headquartered in Toronto, Ontario. The firm is a subsidiary of FIC Holdings ULC and their ultimate parent is 483A Bay Street Holdings LP in Bermuda. Founded in 1987, Fidelity Investments Canada provides Canadian investors a full range of domestic, international and global equity and income-oriented mutual funds, as well as asset allocation, managed solutions, ETFs, sustainable investment funds and a high-net-worth program.

Hillsdale Investment Management, Inc. (Hillsdale) is a privately-owned hedge fund manager headquartered in Toronto, Canada. The firm was founded by Albert Guthrie in 1996. Hillsdale offers discretionary investment management services to a range of sophisticated institutional and private wealth investors, primarily in Canada but also in the US and elsewhere.

Quest Investment Fund Management Ltd. is an investment advisor located in Vancouver with an additional office in Calgary. They are a subsidiary of Qwest Investment Management Corp. The firm provides investment advisory, portfolio management services and fund management services. They also manage the Qwest Energy Canadian Specialty Energy Fund, the QE Funds Corp. mutual fund and the Qwest Energy 2009 Flow-Through LP, the Qwest Energy 2009-II Flow-Through LP and the Qwest Energy 2010 Flow-Through LP

Qwest Energy Flow-Through 2015 LP is engages in the oil and natural gas exploration, development and production. The company is managed through its general partner, Qwest Energy Flow-Through 2015 Management Corp. Qwest Energy Flow-Through 2015 on September 3, 2015 and is headquartered in Vancouver, CA.

3iQ Corp. is a holding firm and digital asset investment fund manager headquartered in Toronto, Canada. The firm was founded by Jean-Luc Landry and Frederick Thomas Pye in 2012. 3iQ manages a public bitcoin investment fund – The Bitcoin Fund (TSX: QBTC.U) – and offers exposure to cryptocurrencies via familiar investment products for Canadian individual investors and their advisors, institutions, and both single and multi-family offices.

ImmunoBiochem Corp. is a biopharmaceutical company founded in 2007, based in Canada. The private company is focused on developing biological therapeutics to address unmet needs in oncology and immuno-oncology. ImmunoBiochem has worked closely with the University of Toronto, one of the world's leading institutions in research and innovation, on some of its novel programs. The Canadian company uses high-throughput functional screens, bioinformatics, and AI/ML to discover novel tumor targets in the tumor microenvironment, particularly in the cancer cell secretome. The company is a Johnson & Johnson Innovation JLABS alumnus and is headquartered in the heart of Canada's largest biomedical research hub.

Bitcoin Split Trust operates as a non-redeemable investment fund. The company is headquartered in Toronto, Canada.